SCHEMBL15910941

SCHEMBL15910941

CC(C)CC1(O)CNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15713357 0.82
SCHEMBL15891572 0.81 CYP2D6 (0.33)
SCHEMBL22751976 0.78 SOS1 (0.31)
SCHEMBL8441271 0.75 CYP1A2 (0.31)
SCHEMBL13342084 0.75
SCHEMBL13688301 0.70
SCHEMBL20147297 0.70
SCHEMBL10021005 0.70
SCHEMBL4602173 0.70 ANPEP (0.31)
SCHEMBL21575377 0.70 TSHR (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024019957-A1 COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES CELGENE CORPORATION (US) 2024-01-25 WO disclosed
US-20230165854-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY SHOUTI INC. 2023-06-01 US disclosed
US-11661410-B2 Tricyclic compounds as histone methyltransferase inhibitors GLOBAL BLOOD THERAPEUTICS, INC. (US) 2023-05-30 US disclosed
US-20230049231-A1 ARYL HETEROBICYCLIC COMPOUNDS AS Kv1.3 POTASSIUM SHAKER CHANNEL BLOCKERS D. E. SHAW RESEARCH, LLC 2023-02-16 US disclosed
US-20220125787-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY ANNAPURNA BIO, INC. 2022-04-28 US disclosed
US-20200369626-A1 COMPOSITIONS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR 2 (S1PR2) BINDING AGENTS AND USES THEREOF WASHINGTON UNIVERSITY (US) 2020-11-26 US disclosed
US-20200369626-A1 COMPOSITIONS OF SPHINGOSINE-1-PHOSPHATE RECEPTOR 2 (S1PR2) BINDING AGENTS AND USES THEREOF WASHINGTON UNIVERSITY (US) 2020-11-26 US disclosed
US-10835520-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2020-11-17 US disclosed
WO-2020073011-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH APJ RECEPTOR ACTIVITY ANNAPURNA BIO, INC. (US) 2020-04-09 WO disclosed
US-20190233406-A1 HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS MERCK SHARP & DOHME CORP. (US) 2019-08-01 US disclosed
US-9820980-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2017-11-21 US disclosed
US-20170174674-A1 HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS MERCK SHARP & DOHME CORP. (US) 2017-06-22 US disclosed
US-20170174674-A1 HYDROXYALKYLAMINE- and HYDROXYCYCLOALKYLAMINE-SUBSTITUTED DIAMINE-ARYLSULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS MERCK SHARP & DOHME CORP. (US) 2017-06-22 US disclosed
EP-3150577-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2017-04-05 EP disclosed
US-20160213660-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2016-07-28 US disclosed
US-9340499-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2016-05-17 US disclosed
US-20150126486-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2015-05-07 US disclosed
US-8975409-B2 Phenyl derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2015-03-10 US disclosed
US-20140235611-A1 PHENYL DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2014-08-21 US disclosed
EP-2762466-A1 PHENYL DERIVATIVE ONO Pharmaceutical Co., Ltd. (JP) 2014-08-06 EP disclosed